Cardiomyopathy_Paediatric
Gene: ANKRD1
limited by ClinGen HCM working group PMID: 30681346
Evidence summary from ClinGen: The ANKRD1 gene has been associated with autosomal dominant hypertrophic cardiomyopathy in 3 probands in 2 publications. 3 unique missense variants have been reported in humans with no family history of cardiomyopathy. ANKRD1 was first associated with this disease in humans in 2009 (Arimura et al.). Experiments in Crocini et al. 2013 suggest a gain-of-function mechanism for variants in this gene. This gene-disease association is supported by expression studies in mature rat cardiomyocytes and the examination of contraction parameters using engineered heart tissues. In summary, there is limited evidence to support this gene-disease association. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease association. This classification was approved by the ClinGen Hypertrophic Cardiomyopathy Working Group on 9/19/2017. This curation was reviewed for its association with hypertrophic cardiomyopathy (HCM) on April 17th, 2020. No new evidence, convincing or otherwise, has been published that would change this classification. In summary, there is still limited evidence to support this gene-disease association.Created: 19 Jun 2020, 11:37 a.m. | Last Modified: 19 Jun 2020, 11:37 a.m.
Panel Version: 0.28
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
hypertrophic cardiomyopathy
Publications
gene: ANKRD1 was added gene: ANKRD1 was added to Cardiomyopathy_Paediatric. Sources: NHS GMS,Expert Review Red,London South GLH,South West GLH Mode of inheritance for gene: ANKRD1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: ANKRD1 were set to Dilated Cardiomyopathy, Dominant